{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:36:02Z","timestamp":1782398162129,"version":"3.54.5"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Hidradenitis suppurativa (HS) is a chronic cutaneous and systemic inflammatory condition. Increasingly, reports have found that immunoglobulins play a role in the exaggerated immune response occurring in severe HS. It is important to recognize these implications as HS patients may present with laboratory abnormalities relating to chronic inflammation and immune activation. If these laboratory abnormalities are mistakenly associated with another disease process, it could lead to invasive workup and treatment, causing harm to patients. We describe the case of a 23-year-old woman with Hurley stage III HS who was hospitalized and found to have persistent immunoglobulin-G4 (IgG4) elevation. Upon discharge, the patient was diagnosed with IgG4-related disease (IgG4-RD) and started treatment with azathioprine. However, the biopsy ultimately was negative for IgG4-RD, and she presented to our clinic several months later with worsening HS disease during an active flare. Physical examination revealed actively draining nodules and sinus tracts in the bilateral axillae, inguinal folds, and mons pubis region. A confusing laboratory marker with HS was observed in this case. IgG4 has the potential to inhibit or activate inflammation depending on the context, and so IgG4 elevation has been noted in varying disease states. IgG4 elevation is observed in chronic inflammatory states and may represent a compensatory response by the body. While no other cases have reported the association between HS and IgG4 elevation, IgG levels have been found to reflect HS disease severity. Therefore, IgG4 could play a potential role in HS disease monitoring, and awareness of this association is important for providers when managing patients with HS.<\/jats:p>","DOI":"10.3389\/fmed.2024.1471226","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T04:25:56Z","timestamp":1728620756000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["IgG4 serologic elevation in a patient with severe hidradenitis suppurativa: a case report and review of the literature"],"prefix":"10.3389","volume":"11","author":[{"given":"Andrew J.","family":"Gauger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Callie B.","family":"Burgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,11]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1046\/j.1365-2133.2001.04137.x","article-title":"Morbidity in patients with hidradenitis suppurativa","volume":"144","author":"von der Werth","year":"2001","journal-title":"Br J Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fmed.2020.00068","article-title":"Hidradenitis suppurativa: current understanding of pathogenic mechanisms and suggestion for treatment algorithm","volume":"7","author":"Seyed Jafari","year":"2020","journal-title":"Front Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000491547","article-title":"Hurley III hidradenitis suppurativa has an aggressive disease course","volume":"234","author":"Vanlaerhoven","year":"2018","journal-title":"Dermatology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2147\/CCID.S111019","article-title":"Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment","volume":"10","author":"Napolitano","year":"2017","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e011","DOI":"10.1097\/JW9.0000000000000011","article-title":"Treatment of hidradenitis suppurativa resolves associated hematologic abnormalities","volume":"8","author":"Morss-Walton","year":"2022","journal-title":"Int J Womens Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.aav5908","article-title":"Neutrophil extracellular traps, B cells, and type I interferons contribute to immune dysregulation in hidradenitis suppurativa","volume":"11","author":"Byrd","year":"2019","journal-title":"Sci Transl Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"13800","DOI":"10.3390\/ijms232213800","article-title":"Serum immunoglobulin G is a marker of hidradenitis suppurativa disease severity","volume":"23","author":"Mintoff","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e0203672","DOI":"10.1371\/journal.pone.0203672","article-title":"Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and a plasma cell signature","volume":"13","author":"Hoffman","year":"2018","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/exd.14092","article-title":"Beyond antibodies: B cells in hidradenitis suppurativa: bystanders, contributors or therapeutic targets?","volume":"29","author":"Frew","year":"2020","journal-title":"Exp Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"787422","DOI":"10.3389\/fimmu.2021.787422","article-title":"The role of IgG4 in autoimmunity and rheumatic diseases","volume":"12","author":"Maslinska","year":"2022","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"602809","DOI":"10.1155\/2012\/602809","article-title":"Pathologies associated with serum IgG4 elevation","volume":"2012","author":"Ebbo","year":"2012","journal-title":"Int J Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e000661","DOI":"10.1136\/jitc-2020-000661","article-title":"An immune evasion mechanism with IgG4 playing an essential role in cancer and implication for immunotherapy","volume":"8","author":"Wang","year":"2020","journal-title":"J Immunother Cancer"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"635293","DOI":"10.1155\/2014\/635293","article-title":"Elevated serum IgG4 defines specific clinical phenotype of rheumatoid arthritis","volume":"2014","author":"Chen","year":"2014","journal-title":"Mediat Inflamm"},{"key":"ref14","first-page":"253","article-title":"IgG-4 related disease: an introduction","volume":"115","author":"Al-Khalili","year":"2018","journal-title":"Mo Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jid.2021.07.187","article-title":"Autoantibodies present in hidradenitis suppurativa correlate with disease severity and promote the release of Proinflammatory cytokines in macrophages","volume":"142","author":"Carmona-Rivera","year":"2022","journal-title":"J Invest Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1111\/all.13471","article-title":"IgG4 anti-infliximab in treated patients: clinical impact and temporal evolution","volume":"73","author":"Vultaggio","year":"2018","journal-title":"Allergy"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1007\/s10875-012-9705-0","article-title":"IgG4 production against adalimumab during long term treatment of RA patients","volume":"32","author":"van Schouwenburg","year":"2012","journal-title":"J Clin Immunol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3390\/biomedicines10030558","article-title":"Frequency and clinical significance of elevated IgG4 in rheumatoid arthritis: a systematic review","volume":"10","author":"Sakthiswary","year":"2022","journal-title":"Biomedicine"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3390\/jpm13020309","article-title":"Serum immunoglobulin G (IgG) subclasses in a cohort of systemic sclerosis patients","volume":"13","author":"Pellicano","year":"2023","journal-title":"J Pers Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1365-2249.2007.03545.x","article-title":"Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities","volume":"151","author":"Gonzalez-Quintela","year":"2008","journal-title":"Clin Exp Immunol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1471226\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T04:25:58Z","timestamp":1728620758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1471226\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,11]]},"references-count":21,"alternative-id":["10.3389\/fmed.2024.1471226"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1471226","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,11]]},"article-number":"1471226"}}